Abstract
The present invention discloses the use of RNA inhibitory molecules, particularly si RNA molecules silencing the expression of Voltage-Dependent Ion Chanel- (VDAC1) for the induction of cancer stem cell differentiation and reduction of TAMs abundance and tumor angiogenesis, thereby preventing tumor invention and recurrence.
Original language | English |
---|---|
Patent number | WO2017081686 |
IPC | C12Q 1/ 68 A I |
Priority date | 10/11/15 |
State | Published - 18 May 2017 |